Search research articles
Contact Us
Filters
Showing results (31-40 of 87) with videos related to
Page
of 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
July 16, 2013
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway
Jodie P Goodridge, Ni Lee, Aura Burian, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer
Jeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Blood
|
August 27, 2009
Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells
Harlan S Robins, Paulo V Campregher, Santosh K Srivastava, et al.
Plos One
|
November 27, 2013
Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice
Jeffrey Chou, Matthew P Fitzgibbon, Christie-Lynn L Mortales, et al.
Blood
|
November 23, 2016
Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease
Paul J Martin, David M Levine, Barry E Storer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2004
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens
Scott S Tykodi, Edus H Warren, John A Thompson, et al.
Blood
|
March 6, 2010
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
Marie Bleakley, Brith E Otterud, Julia L Richardt, et al.
Blood
|
January 28, 2012
Evaluation of published single nucleotide polymorphisms associated with acute GVHD
Jason W Chien, Xinyi Cindy Zhang, Wenhong Fan, et al.
Scientific Reports
|
January 3, 2024
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
Cindy Y Jiang, Lili Zhao, Michael D Green, et al.
Blood
|
August 4, 2012
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT
Edus H Warren, Xinyi Cindy Zhang, Shuying Li, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 87) with videos related to
Sort By:
Page
of 9
Journal of Immunology (Baltimore, Md. : 1950)
|
July 16, 2013
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway
Jodie P Goodridge, Ni Lee, Aura Burian, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer
Jeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Blood
|
August 27, 2009
Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells
Harlan S Robins, Paulo V Campregher, Santosh K Srivastava, et al.
Plos One
|
November 27, 2013
Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice
Jeffrey Chou, Matthew P Fitzgibbon, Christie-Lynn L Mortales, et al.
Blood
|
November 23, 2016
Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease
Paul J Martin, David M Levine, Barry E Storer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2004
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens
Scott S Tykodi, Edus H Warren, John A Thompson, et al.
Blood
|
March 6, 2010
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells
Marie Bleakley, Brith E Otterud, Julia L Richardt, et al.
Blood
|
January 28, 2012
Evaluation of published single nucleotide polymorphisms associated with acute GVHD
Jason W Chien, Xinyi Cindy Zhang, Wenhong Fan, et al.
Scientific Reports
|
January 3, 2024
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
Cindy Y Jiang, Lili Zhao, Michael D Green, et al.
Blood
|
August 4, 2012
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT
Edus H Warren, Xinyi Cindy Zhang, Shuying Li, et al.
Page
of 9